Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PNPLA3 is a gene that encodes a protein involved in lipid metabolism. Variants of this gene, particularly the I148M variant, are associated with an increased risk of developing fatty liver diseases like MASH and NASH by affecting how the body processes fats and repairs liver tissue[1][3][5].
Not applicable as PNPLA3 is a gene
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Patatin-like phospholipase domain-containing 3 (PNPLA3).